Research-Based Evidence: GLP-1's Efficacy A study published in the New England Journal of Medicine revealed that individuals treated with GLP-1 lost, on average, over 15% of their body weight over 68 weeks
None of these clusters are specific to semaglutide- or vehicle-treated HFpEF conditions ( Figure S5B-C ), indicating that semaglutide treatment does not alter the cardiac fibroblast transcriptome to the extent that sample integration, PCA, and Louvain clustering would produce a condition-specific cluster of cardiac fibroblasts
TLR4 expression is increased (1.9-fold) in the squamous epithelium of patients with RE compared to normal esophageal squamous epithelium (50)
Yeah, amazing
Application of differential scanning calorimetry (DSC) and modulated differential scanning calorimetry (MDSC) in food and drug industries
Baseline characteristics, from Lambourg et al , Am J Kidney Dis, 2025 Table 2 shows that before weighting, patients who continued metformin differed from those who stopped it